Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,561 to 1,580 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target. | J Transl Med | 2020 | 32580769 | PubTator, text mining | PubMed |
| Mouse brain transcriptome responses to inhaled nanoparticulate matter differed by sex and APOE in Nrf2-Nfkb interactions. | Elife | 2020 | 32579111 | PubTator, text mining | PubMed |
| Novel Treatment Paradigms in Acute Myeloid Leukemia. | Clin Pharmacol Ther | 2020 | 32572947 | PubTator, text mining | PubMed |
| Impact of Covid-19 on the treatment of acute myeloid leukemia. | Leukemia | 2020 | 32561842 | PubTator, text mining | PubMed |
| Has Drug Repurposing Fulfilled its Promise in Acute Myeloid Leukaemia? | J Clin Med | 2020 | 32560371 | PubTator, text mining | PubMed |
| The "Janus" Role of C/EBPs Family Members in Cancer Progression. | Int J Mol Sci | 2020 | 32560326 | PubTator, text mining | PubMed |
| Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors. | Cancers (Basel) | 2020 | 32560251 | PubTator, text mining | PubMed |
| The Transcription Co-Repressors MTG8 and MTG16 Regulate Exit of Intestinal Stem Cells From Their Niche and Differentiation Into Enterocyte vs Secretory Lineages. | Gastroenterology | 2020 | 32553763 | PubTator, text mining | PubMed |
| [Analysis of Genomic Landscape in Patients with Acute Myeloid Leukemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2020 | 32552938 | PubTator, text mining | PubMed |
| Bone marrow particle enrichment analysis for the laboratory diagnosis of multiple myeloma: A case study. | J Clin Lab Anal | 2020 | 32548852 | PubTator, text mining | PubMed |
| Identification of Early Warning Signals at the Critical Transition Point of Colorectal Cancer Based on Dynamic Network Analysis. | Front Bioeng Biotechnol | 2020 | 32548109 | PubTator, text mining | PubMed |
| Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment. | BMC Cancer | 2020 | 32539815 | PubTator, text mining | PubMed |
| Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia. | Biomark Res | 2020 | 32537166 | PubTator, text mining | PubMed |
| Clinical Characteristics and Prognosis of 27 Patients with Childhood Acute Megakaryoblastic Leukemia. | Med Sci Monit | 2020 | 32532951 | PubTator, text mining | PubMed |
| Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer Development. | Front Cell Dev Biol | 2020 | 32528957 | PubTator, text mining | PubMed |
| Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia. | Blood Cancer J | 2020 | 32527994 | PubTator, text mining | PubMed |
| 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo. | J Immunother Cancer | 2020 | 32527933 | PubTator, text mining | PubMed |
| Embryonic Program Activated during Blast Crisis of Chronic Myelogenous Leukemia (CML) Implicates a TCF7L2 and MYC Cooperative Chromatin Binding. | Int J Mol Sci | 2020 | 32517078 | PubTator, text mining | PubMed |
| Myeloid Sarcomas Causing Unilateral Cranial Nerve Palsies in a Patient with Relapsed Acute Myeloblastic Leukemia. | Case Rep Hematol | 2020 | 32509360 | PubTator, text mining | PubMed |
| Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going. | J Clin Med | 2020 | 32503122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=79